Albert Einstein College Of Medicine
Clinical trials sponsored by Albert Einstein College Of Medicine, explained in plain language.
-
Local health workers bridge gap for young adults with diabetes
Disease control CompletedThis study tested whether specially trained community health workers could help young adults from underrepresented minority groups start and keep using diabetes technology like continuous glucose monitors and insulin pumps. For 9 months, 119 participants were randomly assigned to…
Phase: NA • Sponsor: Albert Einstein College of Medicine • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Personalized cancer combo aims to control advanced lung tumors
Disease control CompletedThis Phase 2 trial tested a personalized treatment approach for patients with locally advanced non-small cell lung cancer (NSCLC). For patients whose tumors had high levels of a specific marker (PD-L1), researchers combined a 4-week personalized radiation course with an immunothe…
Phase: PHASE2 • Sponsor: Albert Einstein College of Medicine • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
New Quit-Smoking program tested for firefighters at high risk for lung cancer
Prevention CompletedThis study tested a new, more proactive way to help retired firefighters quit smoking to prevent lung cancer. It compared a standard quit-smoking program against an enhanced one that automatically enrolled people, used personalized lung scan results for motivation, and started me…
Phase: PHASE4 • Sponsor: Albert Einstein College of Medicine • Aim: Prevention
Last updated Apr 04, 2026 02:20 UTC
-
Text messages fight HIV: WhatsApp trial shows promise for prevention
Prevention CompletedThis study tested whether sending educational messages through WhatsApp could encourage more HIV testing and connection to preventive care among men who have sex with men in India. Researchers enrolled 1,004 participants and randomly assigned them to receive either the WhatsApp m…
Phase: NA • Sponsor: Albert Einstein College of Medicine • Aim: Prevention
Last updated Apr 03, 2026 14:43 UTC
-
Can a Men-Only program stop diabetes before it starts?
Prevention CompletedThis study tested whether a diabetes prevention program tailored for men worked better than the standard program. Over 300 men at risk for diabetes were randomly assigned to either attend the new men-only classes or the usual mixed-gender classes. The goal was to see if the tailo…
Phase: NA • Sponsor: Albert Einstein College of Medicine • Aim: Prevention
Last updated Apr 03, 2026 14:42 UTC
-
Study tests which drug mix makes wisdom tooth surgery smoother
Symptom relief CompletedThis small, completed study compared two common drug combinations used to sedate patients during wisdom teeth removal. Researchers tested how quickly patients recovered, how much they remembered, and how satisfied both patients and surgeons were with each method. The goal was to …
Phase: PHASE1 • Sponsor: Albert Einstein College of Medicine • Aim: Symptom relief
Last updated Apr 04, 2026 02:20 UTC
-
At-Home brain zaps tested to slow Alzheimer's decline
Symptom relief CompletedThis study tested whether a safe, non-invasive brain stimulation device used at home could help people with mild to moderate Alzheimer's disease. One hundred participants used the device for 30 minutes, five days a week for six months to see if it improved memory, thinking skills…
Phase: NA • Sponsor: Albert Einstein College of Medicine • Aim: Symptom relief
Last updated Apr 03, 2026 14:42 UTC
-
Immune protein infusion tested to stop agony of sickle cell crises
Symptom relief CompletedThis study tested whether a single dose of an immune protein therapy (IVIG) could safely shorten severe pain crises in people with sickle cell disease. About 300 children and adults were given either IVIG or a placebo saline solution during a hospital stay for a pain crisis. Rese…
Phase: PHASE1, PHASE2 • Sponsor: Albert Einstein College of Medicine • Aim: Symptom relief
Last updated Mar 31, 2026 12:11 UTC
-
Could cannabis ease the agony of cancer treatment?
Symptom relief CompletedThis study looked at whether adding medical cannabis to standard supportive care helps head and neck cancer patients better tolerate the difficult side effects of combined chemotherapy and radiation. Researchers observed 30 patients who were already certified to use medical canna…
Sponsor: Albert Einstein College of Medicine • Aim: Symptom relief
Last updated Mar 27, 2026 12:39 UTC
-
Virtual help for migraine sufferers: can telehealth reduce headaches?
Symptom relief CompletedThis small pilot study tested whether a 12-week telehealth program could help people manage migraines. Twenty participants with frequent migraines used a mobile app diary, online educational materials, and had video sessions with a provider. The main goal was to see if this appro…
Phase: NA • Sponsor: Albert Einstein College of Medicine • Aim: Symptom relief
Last updated Mar 23, 2026 15:16 UTC
-
Marijuana's hidden risk for older women: study links cannabis to falls
Knowledge-focused CompletedThis study aimed to understand why older women who use cannabis have a higher risk of falling. Researchers compared how cannabis versus a placebo affected walking, balance, and thinking skills in 25 older women, some with HIV and some without. They tested participants under diffe…
Phase: PHASE2 • Sponsor: Albert Einstein College of Medicine • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:43 UTC